Antiparasitic activity of marine pyridoacridone alkaloids related to the ascididemins

Planta Medica

Volumn 69, Issue 6, 2003, Pages 527-531

  Copp, Brent R ^a   Kayser, Oliver ^b   Brun, Reto ^c   Kiderlen, Albrecht F ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Alkaloids; Leishmania; Marine metabolites; Plasmodium; Pyridoacridone; Trypanosoma

Indexed keywords

ANTIPARASITIC AGENT; ASCIDIDEMIN; PYRIDOACRIDONE ALKALOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; LEISHMANIA DONOVANI; MACROPHAGE; MAMMAL CELL; MARINE ENVIRONMENT; MOUSE; MYOBLAST; NONHUMAN; PLASMODIUM FALCIPARUM; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE;

ACRIDINES; ALKALOIDS; ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; LEISHMANIA DONOVANI; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MUSCLE, SKELETAL; MYOBLASTS; PARASITIC SENSITIVITY TESTS; PHENANTHROLINES; PHYTOTHERAPY; PLASMODIUM FALCIPARUM; QUINOLINES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA CRUZI; UROCHORDATA;

ANIMALIA; LEISHMANIA DONOVANI; MAMMALIA; PLASMODIUM FALCIPARUM; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CRUZI;

EID: 0038502412     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40640     Document Type: Article

References (22)

1. World Health Organization Health. A precious asset (accelerating follow-up to the World Summit for Social Development. Proposals by the World Health Organization). World Health Organization, 2000: WHO/HSD/HID/00.1
2. El Sayed KA, Dunbar DC, Goins DK, Cordova CR, Perry TL, Wesson KJ, Sanders SC, Janus SA, Hamann MT. The marine environment: a resouce for prototype antimalarial agents. Journal of Natural Toxins 1996; 5: 261 - 85
3. Molinski TF. Developments in marine natural products. Receptor-specific bioactive compounds. Journal of Natural Products 1993; 56: 1 - 8
4. König GM, Wright AD. Marine natural products research: current directions and future potential. Planta Medica 1996; 62: 193 - 211
5. Ireland CM, Copp BR, Foster MP, McDonald LA, Radisky DC, Swersey JC. Biomedical potential of marine natural products. In: Pharmaceutical and Bioactive Natural Products, Marine Biotechnology Volume 1. Attaway, D, Zaborsky, OR, editors. Plenum Publishing Corp, New York, NY: 1993: pp. 1 - 43
6. Molinski TF. Marine pyridoacridines alkaloids: structure, synthesis, and biological chemistry. Chemical Reviews 1993; 93: 1825 - 38
7. Lindsay BS, Barrows LR, Copp BR. Structural requirements for biological activity of the marine alkaloid ascididemin. Bioorganic and Medicinal Chemistry Letters 1995; 5: 739 - 42
8. Lindsay BS, Christiansen HC, Copp BR. Structural studies of cytotoxic marine alkaloids: Synthesis of novel ring-E analogues of ascididemin and their in vitro and in vivo biological evaluation. Tetrahedron 2000; 56: 497 - 505
9. Copp BR, Hansen RP, Appleton DR, Lindsay BS, Squire CJ, Clark GR, Rickard CEF. A convenient new route to 4-substituted benzo[de] [3],[6]phenanthrolin-6(6H)-ones: Important intermediates in the synthesis of ring-A analogues of the cytotoxic marine alkaloid ascididemin. Synthetic Communications 1999; 29: 2665 - 76
10. Matsumoto SS, Sidford MH, Holden JA, Barrows LR, Copp BR. Mechanism of action studies of cytotoxic marine alkaloids: Ascididemin exhibits thiol-dependent oxidative DNA cleavage. Tetrahedron Letters 2000; 41: 1667 - 70
11. Thaithong S, Beale GH. Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Transactions of the Royal Society of Tropical Medicine and Hygiene 1981; 75: 271 - 3
12. Ponnudurai T, Leeuwenberg AD, Meuwissen JH. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Tropical and Geographical Medicine 1981; 33: 50 - 4
13. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy 1979; 16: 710 - 8
14. Kayser O, Kiderlen AF, Brun R. In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54. Planta Medica 2001; 67: 718 - 21
15. 50 in studies of drug resistance of malaria parasites. Acta Tropica 1993; 55: 257 - 61
16. Baltz T, Baltz D, Giroud C, Crockett J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO Journal 1985; 4: 273 - 7
17. Räz B, Iten M, Grether-Bühler Y, Kaminsky R, Brun R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Tropica 1997; 68: 39 - 47
18. Hills M, Hudson C, Smith PG. Global monitoring of the resistance of the malarial parasites to drugs: statistical treatment of the micro-test data. WHO, 1986: WHO Working paper No. 2.8.5
19. Kayser O, Kiderlen AF, Folkens U, Kolodziej H. In vitro leishmanicidal activity of aurones. Planta Medica 1998; 65: 316 - 9
20. Kayser O, Kiderlen AF. Leishmanicidal activity of aurones. The Tokai Journal of Experimental and Clinical Medicine 1998; 23: 423 - 6
21. Kolodziej H, Kayser O, Kiderlen AF, Ito H, Hatano T, Yoshida T, Foo LY. Antileishmanial activity of hydrolyzable tannins and their modulatory effects on nitric oxide and tumour necrosis factor-alpha release in macrophages in vitro. Planta Medica 2001; 67: 825 - 32
22. Bonnard I, Bontemps N, Lahmy S, Banaigs B, Combaut G, Francisco C, Colson P, Houssier C, Waring MJ, Bailly C. Binding to DNA and cytotoxic evaluation of ascididemin, the major alkaloid from the Mediterranean ascidian Cystodytes dellechiajei. Anti-Cancer Drug Design 1995; 10: 333 - 46